Introduction
Reactive arthritis is a sterile joint inflammation triggered by an infection in another part of the body and is usually associated with Yersinia, Salmonella, Shigella, Campylobacter, and Chlamydia trachomatitis. 1 The exact mechanism of pathogenesis remains elusive but may involve bacterial antigens and/or host susceptibility, such as the human leukocyte antigen (HLA)-B27. 2 Reactive arthritis has been described infrequently in association with staphylococcal infections. We report a case of a 51-year-old male with reactive arthritis secondary to Staphylococcus lugdunensis bacteremia. Details of the case were obtained from chart review and literature review was used to assess for similar reports.
Case report
A 51-year-old male recently diagnosed with pancreatic cancer and currently on chemotherapy presented to the emergency room with left knee pain of 5-day duration, now causing difficulties with movement and ambulation. He denied any direct trauma to the knee or history of similar symptoms. He also admitted to right knee and right shoulder pain that developed 1 day prior. Review of systems was significant only for fevers to 38.9°C at home. His last chemotherapy treatment with gemcitabine and abraxane had been 2 weeks prior. On initial evaluation, he was afebrile with normal vital signs. Physical examination revealed bilateral knees and right shoulder without erythema, swelling, or joint tenderness. There was limited range of motion in the left knee due to pain. Cardiovascular examination was unremarkable and right chest port-a-cath site had no surrounding erythema or tenderness. Initial laboratory studies were normal aside from anemia (hemoglobin 8.4 g/dL) and elevated inflammatory markers with C-reactive protein (CRP) 14.0 mg/dL (reference range < 0.8 mg/dL) and erythrocyte sedimentation rate (ESR) 57 mm/h (reference range ⩽ 12 mm/h). X-rays of the bilateral knees showed no fractures, joint effusions, or soft tissue abnormalities. Magnetic resonance imaging (MRI) of the right shoulder revealed nonspecific pericapsular and fascial edema ( Figure 1 ). Arthrocentesis of the left knee from the day of admission, prior to antibiotic administration, resulted with bloody fluid containing 57,000/cmm red blood cells, 5,496/cmm white blood cells, of which 92% were neutrophils, and negative Gram stain. Blood cultures drawn the day of admission resulted with S. lugdunensis in four out of four bottles. Urine culture also resulted positive for 7 × 10 4 CFU/mL of S. lugdunensis, without any other organisms detected, and the patient was asymptomatic without hematuria or pyuria. The patient was started empirically on intravenous (IV) vancomycin on hospital day 2 after blood culture results and then transitioned to oxacillin IV continuous infusion once antibiotic susceptibility returned. Transthoracic and transesophageal echocardiograms were performed and no vegetations were seen. The likely source of S. lugdunensis bacteremia was an indwelling line (port-a-cath) which was removed and blood cultures cleared within 24 hours. With the initiation of IV antibiotics, the patient's joint pain decreased and was ambulating by hospital day 3. On hospital day 5, the CRP level was 7.6 mg/dL and ESR was 66 mm/h. The patient completed a 4-week antibiotic course following source control and negative blood culture results.
Discussion
S. lugdunensis is a coagulase-negative staphylococcus that lives on the skin and is an infrequent pathogen compared to Staphylococcus aureus and Staphylococcus epidermidis. 3 However, it behaves clinically like S. aureus in that it can cause virulent infections and has a higher mortality rate than other forms of coagulase-negative staphylococci. 4 It has been associated with a wide variety of infections including bloodstream infections, endocarditis, osteomyelitis and prosthetic joint infections, skin and soft tissue infections, central nervous infections, peritonitis, endophthalmitis, and urinary tract infections. 5 Vascular catheter infections are the most common source of S. lugdunensis bacteremia and was the likely source of infection in our patient. 3 Evaluation for endocarditis should be pursued in patients with bacteremia as up to 50% of those with S. lugdunensis-positive blood cultures have been found to have endocarditis. 6, 7 Bacteremia secondary to S. lugdunensis should be treated similarly to S. aureus with removal of intravascular catheters followed by at least 14 days of IV antibiotics. 4 Reactive arthritis-the most probable cause of joint pain in our patient with a culture-negative inflammatory synovitis-has been described infrequently in association with staphylococcal infections. The low leukocyte count of 5496/cmm and the negative Gram stain are inconsistent with septic arthritis. There are few reports demonstrating reactive arthritis in the setting of S. aureus 8, 9 and as a manifestation of toxic shock syndrome. 10 To our knowledge, only one other report exists in association with coagulasenegative staphylococci 11 and no other reports specifically in relation to S. lugdunensis. This case illustrates that reactive arthritis may rarely follow staphylococcal infection and should be considered as an etiology of joint pain in these patients.
Conclusion
Reactive arthritis has been described infrequently in association with staphylococcal infections, both those secondary to S. aureus and coagulase-negative staphylococci. We report a case of case of reactive arthritis in the setting of S. lugdunensis bacteremia. This case illustrates that a possible systemic manifestation of S. lugdunensis bacteremia, in addition to the more common endocarditis, can also include reactive arthritis. Staphylococcal infection should also be considered as an etiology of joint pain in reactive arthritis.
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